PennVet is enrolling young dogs with elbow dysplasia for a study to assess and optimize the benefits of stem cell therapy following arthroscopic surgery for fragmented medial coronoid processes. 

Inclusion criteria:

  • Confirmed diagnosis of fragmented medial coronoid processes (FMCPs)
  • Less than 2 years of age
  • Weight >15kg
  • Clinical signs of arthritis

Benefits include:

  • Arthroscopic surgery and removal of FMCPs
  • Adjunctive stem cell or hyaluronic acid therapy
  • Follow-up care for one year including gait analysis, xrays and CT scan and orthopedic exams

Contact:

Please contact the VCIC @ (215) 573-0302 or vcic@vet.upenn.edu if you would like more information about this clinical study.